2024 Hematology Bluebook
The Hematology Bluebook includes detailed reviews of Leukemia, Lymphoma and Multiple Myeloma, including:
Market Statistics
Disease Overviews
Clinical Algorithms
Clinical Trials and Outcomes
Pipelines and Target MOAs
Company Overviews and Recent Events
This is our signature Oncology Forum publication and serves as a companion piece to our 2024 Oncology Blue Book.
Pages: 146
The Hematology Bluebook includes detailed reviews of Leukemia, Lymphoma and Multiple Myeloma, including:
Market Statistics
Disease Overviews
Clinical Algorithms
Clinical Trials and Outcomes
Pipelines and Target MOAs
Company Overviews and Recent Events
This is our signature Oncology Forum publication and serves as a companion piece to our 2024 Oncology Blue Book.
Pages: 146
The Hematology Bluebook includes detailed reviews of Leukemia, Lymphoma and Multiple Myeloma, including:
Market Statistics
Disease Overviews
Clinical Algorithms
Clinical Trials and Outcomes
Pipelines and Target MOAs
Company Overviews and Recent Events
This is our signature Oncology Forum publication and serves as a companion piece to our 2024 Oncology Blue Book.
Pages: 146